INTRODUCTION {#sec1-1}
============

*Citrus natsudaidai* (*natsumikan*) have been famous citrus fruits and recognized for their medical properties in many countries. Because natsumikan have a large amount of antioxidative nutrients such as Vitamin C and flavonoids, regular consumption of citrus fruit has been considered good for maintaining health. Additionally, constituents of some citrus plants, such as *Aurantii Fructus Immaturus* (*Kijitsu*) prepared from dried immature fruits of *Citrus aurantium var. daidai* and *C. natsudaidai*, have been used to develop useful crude drugs. Usually, kijitsu is used as an aromatic bitter stomachic and expectorant agent; Chun and Sankawa reported kijitsu extract to have an inhibitory effect on passive cutaneous anaphylaxis in rats, and suggested that kijitsu may possess antiallergic properties.\[[@ref1]\] Natsumikan has many bioactive components such as hesperidin, neohesperidin, naringin, nobiletin, tangeretin, and aurapten, each having been well studied for its pharmacological anti-inflammatory,\[[@ref2][@ref3]\] anticarcinogenic,\[[@ref4]\] antioxidant,\[[@ref5]\] and other properties.

Chronic allergic dermatitis is a common skin disease induced by repeated exposure to an allergen. Atopic dermatitis is a typical chronic allergy skin disease with symptoms such as itching, redness, swelling, and small skin blisters. It is usually treated with steroids as a form of topical therapy, but long-term application results in major side effects such as cushingoid features, cataracts, and hyperglycemia. Thus, a safe and effective treatment is required.

At present, allergic dermatitis is easily simulated in experimental animal models by repeated application of haptens such as 2, 4-Dinitrofluorobenzene,\[[@ref6]\] ovalbumin,\[[@ref7]\] and 2, 4, 6-trinitro-1-chlorobenzene (TNCB)\[[@ref8][@ref9]\] which induce allergic inflammation in the skin. A mouse model reflects some aspects of human diseases including atopic dermatitis\[[@ref10]\] or delayed-type hypersensitivity.\[[@ref11]\] The antiallergic effect of some citrus spices was studied *in vivo*. It was reported that extract of unripe *Citrus unshiu* inhibits ear swelling during both the effector and induction phases in picryl chloride-induced dermatitis model mice.\[[@ref12]\] It was also demonstrated that extract of unripe *Citrus hassaku* and its flavanone glycosides, naringin, and neohesperidin showed antiallergic properties in type I and type IV allergy models in mice.\[[@ref13]\] These results suggest that citrus plant extract is beneficial for treatment of allergic dermatitis, but little is known about antiallergic activities of natsumikan. Therefore, the purpose of this study is to examine the effect of peel extracted from immature natsumikan on chronic allergic dermatitis induced by long-term repeated application of TNCB in an experimental mouse model.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

Immature *C. natsudaidai* (natsumikan) were collected in Minamiboso city, Chiba, Japan, in August 2009, and stored at 4°C prior to extraction from their peel. The natsumikan peel contained the following active components per 100 g: hesperidin, 11 mg; neohesperidin, 370 mg; naringin, 780 mg; nobiletin, 1.6 mg; tangeretin, 3.2 mg; and aurapten, 26 mg.

Extraction procedure {#sec2-2}
--------------------

Natsumikan peel (1 215.2 g) was cut into small pieces with scissors and air dried at 50°C for 24 hours in a mechanical air-dryer. Extract was obtained by placing the dried peel (412.4 g) in a 5-fold volume of methanol (Wako, Osaka, Japan) at 40°C for 2 hours. The resulting extract was filtered and concentrated under reduced pressure with the methanol evaporated, then lyophilized with freeze-drying machine (Taitec, Saitama, Japan) to give extract of dried natsumikan peel (14.2 g).

Animals {#sec2-3}
-------

Female, 5-week-old BALB/c mice were obtained from Japan SLC Inc. (Shizuoka, Japan) and were aged 6 weeks at the time of the experiment. The mice were housed under controlled light (7:00-19:00) and temperature (24°C) with food and water available *ad libitum*. All experiments and procedures were approved by the Chiba University Institutional Animal Care and Use Committee.

Reagents and drugs {#sec2-4}
------------------

TNCB was obtained from Tokyo Chemical Industry (Tokyo, Japan). TNCB was dissolved in acetone/olive oil (3 : 1) to 0.8% (w/v) and used for sensitization and challenge. Dexamethasone (Sigma, St. Louis, MO, USA) was used as a positive control in this study.

Sensitization and challenge procedure {#sec2-5}
-------------------------------------

The hair of abdominal regions of mice was shaved with a hair clipper 2 days before sensitization. On day 1, these mice were sensitized with 50 μl of 0.8% TNCB solution to the shaved abdomen, and on day 8, they were challenged with 10 μl of 0.8% TNCB solution applied to the both sides of right ear. After the first challenge, TNCB solution was repeatedly applied to the same area of the right ear every 3 days till day 29.

Treatment {#sec2-6}
---------

Natsumikan (100, 300, or 1 000 mg/kg) or distilled water as vehicle was administrated orally every day from day 1 to 30. Dexamethasone (3 mg/kg) was administrated orally every day from day 1 to 20, and then every other day from day 21 to 30. All compounds were given as suspensions in distilled water, administrated in a volume of 0.1 ml per 10 g body weight; each compound was administered on the day of each application of TNCB solution, 30 minutes beforehand.

Ear thickness {#sec2-7}
-------------

Right and left ear thickness was measured with a micrometer (Mitutoyo, Kanagawa, Japan) under light ether anesthesia, 24 hours after each challenge. Ear swelling was calculated by subtracting the left ear thickness value from the right ear thickness value.

Dermatitis score {#sec2-8}
----------------

A dermatitis score for the right ear was obtained using the method described by Sunada *et al*.\[[@ref14]\] The severity of dermatitis was assessed 48 hours after each challenge on days 22, 25, and 28, and scored for three symptoms-erythema/hemorrhage, excoriation/erosion, and scaling/dryness, according to the following scale: 0 - no symptoms; 1 - mild; 2 - moderate; 3 - severe. The dermatitis score was defined as the total ranging from 0 to 9.

Oxidative stress {#sec2-9}
----------------

Blood samples were collected by orbital puncture, 24 hours after final application of TNCB solution on day 30 under ether anesthesia. Serums were prepared by centrifugation at 1 000 g for 20 minutes at 4°C, and then stored at -30°C. To measure the levels of reactive oxygen metabolites (ROM) in serum, a derivative-reactive oxygen metabolites (d-ROM) test was performed using an FRAS4 (Diacron, Grosseto, Italy), according to the analysis manual. The results are expressed in conventional units (Carratelli Units, U.CARR; 1 U.CARR corresponds to 0.8 mg/l H~2~O~2~ ).

Statistical analysis {#sec2-10}
--------------------

All data are presented in the form mean ± SEM. Statistical significance was analyzed by Dunnett\'s method of multiple comparisons. Values of *P* \< 0.05 were considered statistically significant. All statistical analysis was conducted using StatLight software (Yukms, Tokyo, Japan).

RESULTS {#sec1-3}
=======

Effect of natsumikan on body weight {#sec2-11}
-----------------------------------

Oral administration of natsumikan did not cause a change in body weight compared with vehicle group. On the other hand, dexamethasone resulted in a significant reduction in body weight of the mice from day 9 throughout experimental period \[[Figure 1](#F1){ref-type="fig"}\].

![Effect of natsumikan extract and dexamethasone administration on body weight in mice repeatedly exposed to TNCB. Each symbol represents the mean ± SEM of 7 to 8 mice. \*, \*\*: Significantly different from the vehicle group at P \< 0.05 and *P* \< 0.01, respectively (Dunnett\'s test). N100, N300, and N1000 = Natsumikan at a dose of 100, 300, and 1 000 mg/kg; Dex = Dexamethasone](PR-3-155-g001){#F1}

Inhibition of ear swelling in a model of allergic dermatitis {#sec2-12}
------------------------------------------------------------

As shown in [Figure 2](#F2){ref-type="fig"}, ear swelling was significantly increased in the mouse model of chronic allergic dermatitis, and natsumikan, especially at a dose of 300 mg/kg on day 21 to 30, and 1 000 mg/kg on days 21 and 24, significantly attenuated the increase in ear swelling compared with vehicle group. Dexamethasone significantly reduced the amount of ear swelling during the experimental period.

![Effect of natsumikan extract and dexamethasone administration on ear swelling in mice repeatedly exposed to TNCB. Each symbol represents the mean ± SEM of 7 to 8 mice. \*, \*\*: Significantly different from the vehicle group at *P* \< 0.05 and *P* \< 0.01, respectively (Dunnett\'s test). N100, N300, and N1000 = Natsumikan at doses of 100, 300, and 1 000 mg/kg; Dex = Dexamethasone](PR-3-155-g002){#F2}

Natsumikan improved the dermatitis score in a model of allergic dermatitis {#sec2-13}
--------------------------------------------------------------------------

As shown in [Figure 3](#F3){ref-type="fig"}, repeated application of TNCB resulted in a high dermatitis score in the vehicle group, natsumikan improving the score in dose-dependent manner. Significant decrease in score was seen at day 25 with a dose of 1 000 mg/kg natsumikan. Dexamethasone also showed significant reduction in symptoms of dermatitis throughout the experimental period.

![Effect of natsumikan extract and dexamethasone administration on dermatitis score in mice repeatedly exposed to TNCB. Each symbol represents the mean ± SEM of 7 to 8 mice. \*, \*\*: Significantly different from the vehicle group at *P* \< 0.05 and *P* \< 0.01, respectively (Dunnett\'s test). N100, N300, and N1000: Natsumikan at doses of 100, 300, and 1 000 mg/kg; Dex: Dexamethasone](PR-3-155-g003){#F3}

Effect of natsumikan on serum oxidative stress in allergic dermatitis {#sec2-14}
---------------------------------------------------------------------

Serum oxidative stress manifested higher in the vehicle group than the Nil group; natsumikan at a dose of 300 mg/kg showed a slight decrease \[[Figure 4](#F4){ref-type="fig"}\]. In contrast, dexamethasone did not show obvious reduction in serum oxidative stress.

![Effect of natsumikan extract and dexamethasone administration on degree of oxidative stress in mice repeatedly exposed to TNCB. All values were expressed as mean ± SEM of 7 to 8 mice (Vehicle, N100, N300, N1000 and Dex) and of three mice (Nil). Nil: Nontreatment; N100, N300, and N1000: Natsumikan at doses of 100, 300, and 1 000 mg/kg; Dex: Dexamethasone](PR-3-155-g004){#F4}

DISCUSSION {#sec1-4}
==========

This is the first study to show the effectiveness of natsumikan for allergic dermatitis, in which we have developed a chronic allergic dermatitis mouse model by applying TNCB every three days for 3 weeks and examining the antiallergic activity of extract from immature natsumikan peel.

Citrus peel has been regarded as a byproduct of the citrus fruit industry, but it has been reported to contain several active components at far higher concentration than the pulp. Natsumikan peel contains higher concentration of neohesperidin and naringin than other citrus species.\[[@ref15]\] Furthermore, Kubo *et al*. reported the antiallergic effect of *C. unshiu* to be decreased with its ripening.\[[@ref16]\] Therefore, we focused on the peel extract from unripened natsumikan.

Previous studies have demonstrated the antiallergic effects of citrus species. For example, *C. unshiu* powder attenuated production of pollen-induced inflammatory cytokines by peripheral blood mononuclear cells in seasonal allergic rhinitis patients,\[[@ref2]\] and showed inhibitory effect on ear swelling in a mouse model of picryl chloride-induced contact dermatitis.\[[@ref12]\] In addition, it was reported that neohesperidin and naringin, both typical active citrus components, inhibit ear swelling in a type IV allergic model mouse.\[[@ref13]\] In our study, repeated application of TNCB in mice induced significant ear swelling and serious allergic dermatitis symptoms, which was found to be inhibited by treatment with natsumikan. These results suggest that natsumikan has a beneficial effect on allergic dermatitis which may be mediated by the active components as discussed previously. Furthermore, serum d-ROM value, which indicates oxidative stress, was increased by repeated application of TNCB but reduced by natsumikan, especially at a dose of 300 mg/kg. Thus, it can be hypothesized that oxidative stress is associated with the pathology of allergic dermatitis. It was reported that pathology of atopic dermatitis, a typical allergic dermatitis, was involved in oxidative stress.\[[@ref17]\] In addition, the inflammatory response is known to involve the production of reactive oxygen species at sites of inflammation.\[[@ref18]\] As described above, there is high concentration of neohesperidin in natsumikan peel fraction and it was reported that neohesperidin and its aglycone, hesperetin, are major secondary metabolites in citrus species, both possessing antioxidative properties.\[[@ref19][@ref20]\] Furthermore, some plant resources which possess antioxidant activity demonstrate a potential for an effective management of atopic disease.\[[@ref21][@ref22]\] Therefore, it is assumed that the inhibitory effect of natsumikan on chronic allergic dermatitis in our mouse model may be mediated, at least in part, by its antioxidative properties, but further studies are required to confirm this.

The mice after long-term dexamethasone treatment showed obvious and significant reduction in body weight and immune organ weight (data not shown), these results indicating possible adverse effects from steroid treatment. We hence modified the drug regimen for the dexamethasone group from day 20, from daily treatment to treatment on alternate days. By contrast, natsumikan treatment did not show such effects.

In conclusion, extract of immature natsumikan peel might be an effective natural product to treat chronic allergic dermatitis with no apparent side effects. Our results suggest that natsumikan can be a valuable treatment for several allergic diseases.
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